Literature DB >> 26747622

Long-term survival of an infant with an atypical teratoid/rhabdoid tumor following subtotal resection and low-cumulative dose chemotherapy: a case report.

Viktor Arnhold1, Florian Oyen2, Reinhard Schneppenheim2, Hannes Haberl3, Arend Koch4, Michael C Frühwald5, Pablo Hernáiz Driever6.   

Abstract

INTRODUCTION: Atypical teratoid/rhabdoid tumor (AT/RT) is an aggressive embryonal tumor of the central nervous system with a generally dismal prognosis, especially in patients younger than 12 months. DISCUSSION: We here describe the unusual case of an infant with AT/RT with long-term survival despite low-cumulative dose chemotherapy after subtotal resection. Due to a poor neurological situation and an unfavorable oncological prognosis, therapy was halted after two partial surgical resections and four of the nine chemotherapy courses recommended by the European Rhabdoid Registry, without the patient receiving either radiotherapy or high-dose chemotherapy. The patient is alive without evidence of disease 52 months after diagnosis.
CONCLUSION: This case report highlights that independent prognostic factors are urgently needed for optimizing treatment stratification and preventing overtreatment.

Entities:  

Keywords:  AT/RT; Chemotherapy; Childhood cancer; SMARCB1/Ini1

Mesh:

Substances:

Year:  2016        PMID: 26747622     DOI: 10.1007/s00381-015-2999-5

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  18 in total

Review 1.  INI1-deficient tumors: diagnostic features and molecular genetics.

Authors:  Travis J Hollmann; Jason L Hornick
Journal:  Am J Surg Pathol       Date:  2011-10       Impact factor: 6.394

2.  High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB).

Authors:  M Benesch; K Bartelheim; G Fleischhack; B Gruhn; P G Schlegel; O Witt; K D Stachel; H Hauch; C Urban; F Quehenberger; M Massimino; T Pietsch; M Hasselblatt; F Giangaspero; U Kordes; R Schneppenheim; P Hauser; T Klingebiel; M C Frühwald
Journal:  Bone Marrow Transplant       Date:  2014-01-13       Impact factor: 5.483

3.  Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study.

Authors:  Christelle Dufour; Annick Beaugrand; Marie Cécile Le Deley; Franck Bourdeaut; Nicolas André; Pierre Leblond; Anne-Isabelle Bertozzi; Didier Frappaz; Xavier Rialland; Fanny Fouyssac; Christine Edan; Jacques Grill; Marion Quidot; Pascale Varlet
Journal:  Cancer       Date:  2011-12-16       Impact factor: 6.860

Review 4.  SWI/SNF nucleosome remodellers and cancer.

Authors:  Boris G Wilson; Charles W M Roberts
Journal:  Nat Rev Cancer       Date:  2011-06-09       Impact factor: 60.716

5.  Incidence of atypical teratoid/rhabdoid tumors in children: a population-based study by the Austrian Brain Tumor Registry, 1996-2006.

Authors:  Adelheid Woehrer; Irene Slavc; Thomas Waldhoer; Harald Heinzl; Nadine Zielonke; Thomas Czech; Martin Benesch; Johannes A Hainfellner; Christine Haberler
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

6.  Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database.

Authors:  Katja von Hoff; Bernward Hinkes; Elke Dannenmann-Stern; André O von Bueren; Monika Warmuth-Metz; Niels Soerensen; Angela Emser; Isabella Zwiener; Paul G Schlegel; Joachim Kuehl; Michael C Frühwald; Rolf D Kortmann; Torsten Pietsch; Stefan Rutkowski
Journal:  Pediatr Blood Cancer       Date:  2011-07-27       Impact factor: 3.167

7.  Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers.

Authors:  N Sévenet; E Sheridan; D Amram; P Schneider; R Handgretinger; O Delattre
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

8.  Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis.

Authors:  Jonathon Torchia; Daniel Picard; Lucie Lafay-Cousin; Cynthia E Hawkins; Seung-Ki Kim; Louis Letourneau; Young-Shin Ra; King Ching Ho; Tiffany Sin Yu Chan; Patrick Sin-Chan; Christopher P Dunham; Stephen Yip; Ho-Keung Ng; Jian-Qiang Lu; Steffen Albrecht; José Pimentel; Jennifer A Chan; Gino R Somers; Maria Zielenska; Claudia C Faria; Lucia Roque; Berivan Baskin; Diane Birks; Nick Foreman; Douglas Strother; Almos Klekner; Miklos Garami; Peter Hauser; Tibor Hortobágyi; Laszló Bognár; Beverly Wilson; Juliette Hukin; Anne-Sophie Carret; Timothy E Van Meter; Hideo Nakamura; Helen Toledano; Iris Fried; Daniel Fults; Takafumi Wataya; Chris Fryer; David D Eisenstat; Katrin Scheineman; Donna Johnston; Jean Michaud; Shayna Zelcer; Robert Hammond; David A Ramsay; Adam J Fleming; Rishi R Lulla; Jason R Fangusaro; Nongnuch Sirachainan; Noppadol Larbcharoensub; Suradej Hongeng; Muhammad Abrar Barakzai; Alexandre Montpetit; Derek Stephens; Richard G Grundy; Ulrich Schüller; Theodore Nicolaides; Tarik Tihan; Joanna Phillips; Michael D Taylor; James T Rutka; Peter Dirks; Gary D Bader; Monika Warmuth-Metz; Stefan Rutkowski; Torsten Pietsch; Alexander R Judkins; Nada Jabado; Eric Bouffet; Annie Huang
Journal:  Lancet Oncol       Date:  2015-04-14       Impact factor: 41.316

9.  Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy.

Authors:  Tal Finkelstein-Shechter; Adam Gassas; Donald Mabbott; Annie Huang; Ute Bartels; Uri Tabori; Laura Janzen; Janzen Laura; Cynthia Hawkins; Michael Taylor; Eric Bouffet
Journal:  J Pediatr Hematol Oncol       Date:  2010-07       Impact factor: 1.289

10.  Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor.

Authors:  Susan N Chi; Mary Ann Zimmerman; Xiaopan Yao; Kenneth J Cohen; Peter Burger; Jaclyn A Biegel; Lucy B Rorke-Adams; Michael J Fisher; Anna Janss; Claire Mazewski; Stewart Goldman; Peter E Manley; Daniel C Bowers; Anne Bendel; Joshua Rubin; Christopher D Turner; Karen J Marcus; Liliana Goumnerova; Nicole J Ullrich; Mark W Kieran
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.